Skip to content

Type: Press Releases

New Manuscript Shows Changes In CtDNA Reflect Clinical Benefit To Patients

Statement From Friends of Cancer Research on Monica Bertagnolli’s Nomination as Director of The National Cancer Institute

Friends of Cancer Research Statement on the VALID Act of 2022

New Research Shows Breakthrough Therapy Designated Drugs Provide Maximum Benefit to Patients

Friends of Cancer Research Statement on the Proposed House and Senate FDA User Fee Legislation

Dr. Ned Sharpless Stepping Down as National Cancer Institute Director

Statement from Friends of Cancer Research on Dr. Robert Califf’s Confirmation as FDA Commissioner

Statement from Friends of Cancer Research on President & Dr. Biden’s Cancer Moonshot

New HRD Publication Sets the Stage for Unique Collaboration

Washington, DC – January 27, 2022 – Friends of Cancer Research (Friends) is excited to announce its latest publication “Homologous Recombination Deficiency: Concepts, Definitions, and Assays.” Findings from this manuscript set the foundation for the ongoing Homologous Recombination Deficiency (HRD) Harmonization Project, a unique research partnership focused on developing strategies to assess assay performance and…

Dr. Robert Califf Letter of Support 2021